Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

被引：11
|
作者：
Ruzzo, A. [1 ]
Canestrari, E. [1 ]
Galluccio, N. [1 ]
Santini, D. [2 ]
Vincenzi, B. [2 ]
Tonini, G. [2 ]
Magnani, M. [1 ]
Graziano, F. [3 ]
机构：
[1] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy
[2] Univ Campus Biomed, Med Oncol Unit, Rome, Italy
[3] Azienda Osped San Salvatore, Dept Oncohematol, Div Oncol, Pesaro, Italy
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷 / 01期
关键词：
CETUXIMAB; BRAF;
D O I：
10.1093/annonc/mdq472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：234 / U274
页数：2
相关论文
共 50 条
  • [1] KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?
    Zhang, W.
    LaBonte, M. J.
    Lenz, H. -J.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 484 - U267
  • [2] The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients
    Sebio, Ana
    Pare, Laia
    Paez, David
    Salazar, Juliana
    Gonzalez, Alan
    Sala, Nuria
    del Rio, Elisabeth
    Martin-Richard, Marta
    Tobena, Maria
    Barnadas, Agusti
    Baiget, Montserrat
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (03): : 142 - 147
  • [3] The relationship between KRAS LCS6 polymorphism and endometrium cancer
    Cintesun, Feyza Nur Incesu
    Kerimoglu, Ozlem Secilmis
    Cintesun, Ersin
    Nergiz, Suleyman
    Acar, Hasan
    Celik, Cetin
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 40 (07) : 988 - 993
  • [4] A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
    Smits, Kim M.
    Paranjape, Trupti
    Nallur, Sunitha
    Wouters, Kim A. D.
    Weijenberg, Matty P.
    Schouten, Leo J.
    van den Brandt, Piet A.
    Bosman, Fred T.
    Weidhaas, Joanne B.
    van Engeland, Manon
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7723 - 7731
  • [5] Effects of kras gene lcs6 mutation on metastasis pathways in human lung cancer
    Azzawri, A. A.
    Cora, T.
    Acar, H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [6] A let-7 KRAS rs712 polymorphism increases colorectal cancer risk
    Pan, Xin-Min
    Sun, Rui-Fen
    Li, Zhao-Hui
    Guo, Xiao-Min
    Zhang, Zhen
    Qin, Hao-Jie
    Xu, Guo-Hui
    Gao, Lin-Bo
    TUMOR BIOLOGY, 2014, 35 (01) : 831 - 835
  • [7] Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
    Sclafani, F.
    Chau, I.
    Cunningham, D.
    Peckitt, C.
    Lampis, A.
    Hahne, J. C.
    Braconi, C.
    Tabernero, J.
    Glimelius, B.
    Cervantes, A.
    Begum, R.
    De Castro, D. Gonzalez
    Wilson, S. Hulkki
    Eltahir, Z.
    Wotherspoon, A.
    Tait, D.
    Brown, G.
    Oates, J.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1936 - 1941
  • [8] Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
    F Graziano
    E Canestrari
    F Loupakis
    A Ruzzo
    N Galluccio
    D Santini
    M Rocchi
    B Vincenzi
    L Salvatore
    C Cremolini
    C Spoto
    V Catalano
    S D'Emidio
    P Giordani
    G Tonini
    A Falcone
    M Magnani
    The Pharmacogenomics Journal, 2010, 10 : 458 - 464
  • [9] Assessing the biological and biochemical consequences of the let-7 SNP within the 3′UTR of KRAS
    Crowley, E.
    Arena, S.
    Bardelli, A.
    FEBS JOURNAL, 2011, 278 : 201 - 202
  • [10] A SNP IN LET-7 MIRNA BINDING SITE IN THE KRAS ONCOGENE INCREASES RISK OF TRIPLE NEGATIVE BREAST CANCER
    Heneghan, H. M.
    Miller, N.
    Paranjape, T.
    Slack, F. J.
    Weidhaas, J. B.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : 20 - 20
12345